What is CD4+CD56+ malignancy and how should it be treated?
about
Blastic Plasmacytoid Dendritic Cell Neoplasm in the Pediatric Population: A Case Series and Review of the LiteratureBlastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches.Blastic Plasmacytoid Dendritic Cell Neoplasm with Pulmonary Involvement and Atypical Skin Lesion.Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for acute lymphoblastic leukemia.Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications.A rare case of blastic plasmacytoid dendritic cell neoplasm with deletion 7q.31, in the setting of heavy pre-treatment with alkylating chemotherapy.Blastic Plasmacytoid Dendritic Cell Neoplasm: Analysis of Clinicopathological Feature and Treatment Outcome of Seven Cases.Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review.Blastic plasmacytoid dendritic cell neoplasm: a single-center experience.Diffuse lung metastases in a child with blastic plasmacytoid dendritic cell neoplasm and review.Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.Infiltrative plaques on the temple. Blastic plasmacytoid dendritic cell neoplasm (BPDCN).Reduced intensity allogeneic stem cell transplant for treatment of blastic plasmacytoid dendritic cell neoplasm.Neoplasms derived from plasmacytoid dendritic cells.Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).Flow cytometry to identify bone-marrow relapse in blastic plasmacytoid dendritic cell neoplasm: a case report.Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in KoreaEfficacy of acute myeloid leukemia therapy without stem-cell transplantation in a child with blastic plasmacytoid dendritic cell neoplasm.A case of blastic plasmacytoid dendritic cell neoplasm.Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN.Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasm.Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.CLTC-ALK fusion as a primary event in congenital blastic plasmacytoid dendritic cell neoplasm.Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study.Clonal evolution in the transition from cutaneous disease to acute leukaemia suggested by liquid biopsy in blastic plasmacytoid dendritic cell neoplasm.Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation--a single center experience.Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern.Azacitidine in the treatment of blastic plasmacytoid dendritic cell neoplasm: a report of 3 cases.Intracytoplasmic detection of TCL1--but not ILT7-by flow cytometry is useful for blastic plasmacytoid dendritic cell leukemia diagnosis.Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms.Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm
P2860
Q28083657-71DA00DF-9F57-4473-8C9F-60F2D161CFE9Q30249813-75D68912-66F1-40B2-B5C1-6BE5A52A1A10Q33841199-46AC6281-BD11-44FA-B351-D4B0F6CBCB74Q34096751-24AF3AA1-9AB7-4FE6-9E3F-7B1D9425C68CQ34227741-DBD4B205-A22C-4522-9549-4AA295533C08Q34255104-5D9C0075-005A-42DB-BC08-A39F57E61353Q34538446-F881113F-C4AB-427C-B049-AF0AE84D80FDQ36415215-20370090-3229-49B3-871B-36CB4C9E1548Q36579106-E5C02D41-EE62-4C32-8E6E-D57BABF97080Q36762575-72AB4F2C-961F-4000-8A36-9CA51EC95D0BQ37975056-0F6929BB-109D-4D78-A188-6096AA039079Q38058425-FAA0E7D1-73E0-4456-A9DA-D6146A4B5A84Q38175299-037181BC-3C84-47C3-8DD3-1D58D7EACECCQ38213642-B398FE9B-BCCA-48A2-AD42-F4B9C7EEF66EQ38259612-A0447CF6-6A62-42D5-92BA-D90579CAB9A3Q38388125-F5D5995D-AF2E-4732-8BA1-46B09754CE28Q38628866-96D544A8-6537-4CB4-8B49-4E8D348D3281Q38689894-FDA67D92-082B-44EF-80DD-792A08C51C36Q38918870-EDC90BDE-6708-466C-867D-DCBAF06D41BCQ41491107-61C7FD6B-73E0-44E8-8AFF-AB12A77F4A85Q41607602-E8AAA9C0-2A0F-405C-8113-53ACD97B5333Q43156053-8FD36114-34E6-47C4-8454-211FDA15448DQ43165415-A9590C9E-C6D9-4E47-982A-028B01A4EB71Q46058919-97209EF9-7574-4A94-818E-C143B0F19FDFQ46112355-02929F93-76D3-45CD-A49D-671678E1770CQ46118251-9D5361B1-DBD0-4509-A498-145DD80E0EFEQ46465423-B71F0866-97CD-4C8E-A9E8-5E059CF5E0DCQ47567814-A97598FA-A84C-4D57-B9F7-ACA801A5CC25Q50118860-E4C17F17-63CC-4388-8705-52E8C482D005Q50643131-26C58AAB-BA90-44E0-9154-D3F5E0B2841AQ52648918-41AE8FEA-A9B4-4700-8B95-7AB512446CACQ52880354-1EBD68B3-BDEC-43DA-B41C-0231BCE8B3DFQ53269527-5DA744AC-2F83-469B-8645-4B46636E51B5Q53641555-0106C718-E682-4A50-8CCA-59B55B77ABA2Q55085208-2AF22B8D-2D2A-4233-A96A-46EB9CB749B1Q58010082-52B49040-8A19-4A73-87FE-EB4493644A56
P2860
What is CD4+CD56+ malignancy and how should it be treated?
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
What is CD4+CD56+ malignancy and how should it be treated?
@ast
What is CD4+CD56+ malignancy and how should it be treated?
@en
type
label
What is CD4+CD56+ malignancy and how should it be treated?
@ast
What is CD4+CD56+ malignancy and how should it be treated?
@en
prefLabel
What is CD4+CD56+ malignancy and how should it be treated?
@ast
What is CD4+CD56+ malignancy and how should it be treated?
@en
P2093
P2860
P356
P1476
What is CD4+CD56+ malignancy and how should it be treated?
@en
P2093
Konrad Müller-Hermelink H
Kunzmann V
Weissinger F
P2860
P2888
P304
P356
10.1038/SJ.BMT.1704215
P407
P577
2003-10-01T00:00:00Z